Computer Vision has already revolutionized other industries. The vision systems that Constellation builds on are much like the ones that proved effective in sending a driverless car coast-to-coast.
Partly because Constellation’s development relies on existing innovations, this potentially life-saving technology can be demonstrated to the market in less than one year.
Concerns over skin cancer have grown exponentially in recent years. Those with increased risk of skin cancer are spending billions annually on dermatologist visits and mole removal, and spending on sunscreen products and SPF clothing continues to climb. Despite the growing awareness and spending, skin cancer rates increase every year.
In 2011, revenues in the U.S. dermatology market climbed to approximately $10 billion.¹
IBISWorld cites high skin cancer rates as a driving force in the $1 billion U.S. sunscreen market.²
In terms of incidence rates, melanoma is one of the fastest growing cancers. The American Cancer Society estimates that 76,690 people in the United States will be diagnosed with melanoma in 2013.
According to the Pew Research Center, one in three American adults are “online diagnosers,” or have gone online to help determine if they have a medical condition.³ As technology has become more advanced, consumers want to take control over their health. Demand for at-home diagnostic tools has grown, and more and more smartphone apps are promising to alert consumers to possible signs of skin cancer. While these apps are growing in popularity, they are extremely limited in their effectiveness. Constellation is in an entirely different category, providing whole-body scanning, flagging subtle mole changes, and promising to change the future of early skin cancer detection resulting in easier treatment.
1. Source: Dermatologists in the US: Market Research Report.” IBISWorld, Dec 2011.
2. Source: Sunscreen Manufacturing in the US: Market Research Report.” IBISWorld, Nov 2012.
3. Source: Health Online 2013.” Pew Research Center’s Internet & American Life Project, January 15, 2013.
When detected early, skin cancer has a cure rate of 99%. But without early detection, survival rates for melanoma plummet. After metastasis, there is virtually no effective treatment for melanoma skin cancer.
Mole changes are the clearest indicators of possible skin cancer. These changes can be subtle and rather rapid, occurring between dermatologist visits. According to the Melanoma Research Foundation (MRF), the majority of melanomas are found by patients, not by physicians.
Constellation gives patients a powerful new way to perform monthly scans that monitor hundreds of moles, virtually everywhere on the body, and detect even subtle changes.
An affordable price point puts Constellation within reach of a sizeable consumer segment that will welcome a way to conduct quick, monthly scans in the privacy of their homes. Commercial segments also offer diversified revenue opportunities:
In addition, Constellation lends itself to mobile screening programs aimed at underserved, high-risk populations such as agricultural workers.
Constellation leverages existing technology in groundbreaking ways. Leading scientists from MIT and Harvard are among those lending their depth of expertise to this project.
Darrell S. Rigel, MD; Robert J. Friedman, MD; Alfred W. Kopf, MD; David Polsky, MD
Arch Dermatol. 2005;141(8):1032-1034. doi:10.1001/archderm.141.8.1032.
The American Academy of Dermatology and the Centers for Disease Control and Prevention
Supplement to the Journal of the American Academy of Dermatology, November 2011.
Gachon, J; Beaulieu P; Sei JF; Gouvernet J; Claudel J; Lemaitre M; Richard MA; Grob JJ
Arch Dermatol. 2005 Apr;141(4):434-8.
Howard K. Koh, MD; Alan C. Geller; Donald R. Miller, ScD; Ted A. Grossbart, PhD; Robert A. Lew, PhD
Arch Dermatol. 1996;132(4):436-443. doi:10.1001/archderm.
Scope A; Dusza SW; Halpern AC; Rabinovitz H; Braun RP; Zalaudek I; Argenziano G; Marghoob AA
Arch Dermatol. 2008 Jan;144(1):58-64. doi: 10.1001/archdermatol.2007.15.
We value your interest in Constellation. While we do collect personal information upon your approval, such as email addresses, we will never share this information with any other source. We respect the privacy of our viewers and customers and know you hate getting junk mail and spam as much as we do. Email addresses will never be sold or added to a public list in any way, and unless you have selected to be on our email list, you will never receive any form of email.
If you have any questions about this policy or our website, email us at email@example.com
IMPORTANT – READ THESE TERMS AND CONDITIONS OF USE CAREFULLY BEFORE ACCESSING OR USING THIS CONSTELLATION DIAGNOSTICS (ALONG WITH ITS SUBSIDIARIES AND BUSINESSES (“CONSTELLATION”) WEBSITE (THE “WEBSITE”), SUBSCRIBING TO CONSTELLATION SERVICES, PURCHASING CONSTELLATION PRODUCTS, DOWNLOADING CONSTELLATION SOFTWARE, TECHNOLOGY, CONTENT OR DATA AND/OR OTHERWISE USING THE CONSTELLATION SERVICES AND PRODUCTS, AND THE RELATED CONSTELLATION SOFTWARE, DATA AND/OR TECHNOLOGY USED, STORED, LICENSED OR ACCESSED IN CONNECTION THEREWITH AND THE RELATED INTELLECTUAL PROPERTY RIGHTS EMBODIED THEREIN (COLLECTIVELY, THE “CONSTELLATION TECHNOLOGY”).
CONSTELLATION IS WILLING TO PROVIDE YOU WITH LIMITED ACCESS TO THE CONSTELLATION TECHNOLOGY THROUGH THE WEBSITE AND MAKE AVAILABLE CONSTELLATION PRODUCTS AND SERVICES TO YOU ONLY UPON THE CONDITION THAT YOU ACCEPT ALL OF THE TERMS AND CONDITIONS SET FORTH HEREIN, ON ANY REGISTRATION OR ORDER FORM RECEIVED BY YOU FROM CONSTELLATION OR ITS AFFILIATES IN CONNECTION WITH THE CONSTELLATION TECHNOLOGY AND ON ANY DOCUMENTS REFERENCED HEREIN OR ANY ADDITIONAL TERMS AND CONDITIONS THAT CAN BE VIEWED EITHER ON THE PAGES CONTAINING ANY SERVICES OR OFFERINGS, OR VIA A LINK ON THOSE PAGES OR OTHER DIRECTIONS TO THE ADDITIONAL TERMS AND CONDITIONS (COLLECTIVELY, THE “AGREEMENT”).
IF YOU DO NOT AGREE TO THE TERMS STATED BELOW, PROMPTLY CEASE ACCESSING OR OTHERWISE USING THE CONSTELLATION TECHNOLOGY, AND/OR EXIT THIS PAGE BEFORE DOWNLOADING, ACCESSING, USING, SUBSCRIBING OR INSTALLING THE CONSTELLATION TECHNOLOGY OR PURCHASING PRODUCTS AND SERVICES FROM CONSTELLATION.
All designs are property of Constellation Diagnostics and may not be copied or reproduced with written consent. Website designed and maintained by Telegraph Branding.
The Website is intended for residents of the United States and is operated in the State of Massachusetts, United States of America. Constellation Diagnostics and its respective parents, subsidiaries, affiliates, successors, assigns, employees, agents, directors, officers and shareholders make no representation that the content provided through the Constellation Diagnostics Technology is applicable or appropriate for use in jurisdictions other than the United States of America. If you access the Constellation Diagnostics Technology (including, but not limited to, the Website) from outside of the United States, please be aware you are responsible for compliance with any applicable laws. To the extent any applicable local laws prohibit your viewing and use of the Constellation Diagnostics Technology, you may not view or use the Constellation Diagnostics Technology.
© 2013 All Rights Reserved, designed by TeoThemes